Leveraging Mammalian Therapeutic Research To Identify Novel Lead Chemistries for Crop Protection

被引：0

作者：

Hunter, James E. ^{[1
]}

Loso, Michael ^{[1
]}

Tisdell, Francis E. ^{[1
]}

Yap, Maurice C. H. ^{[1
]}

机构：

[1] Dow AgroSci LLC, Discovery Res, Indianapolis, IN 46268 USA

来源：

DISCOVERY AND SYNTHESIS OF CROP PROTECTION PRODUCTS | 2015年 / 1204卷

关键词：

MICROCOLIN-A; DISCOVERY; DERIVATIVES; FUNGICIDES; AGONISTS; DESIGN; TARGET;

D O I：

暂无

中图分类号：

S3 [农学（农艺学）];

学科分类号：

0901 ;

摘要：

Driven by pest resistance and the ever changing demands of the market place, the discovery of new modes of action and lead chemistries with the potential to evolve into novel agricultural products is of prime importance to any crop protection discovery program. One proven inspirational resource for hypotheses which can unearth new agriculturally relevant lead chemistries is the medicinal literature. With the tremendous amount of basic and applied research being conducted to understand as well as exploit mammalian biology, biochemistry and the pathogens that act on them, new therapeutic modes of action, target site ligands and/or biologically privileged chemical motifs continually find their way to the open literature. In this paper some strategies to exploit this wealth of information to identify novel insecticidal and fungicidal lead chemistries will be discussed. Several case studies will be given to illustrate some of the advantages and drawbacks in this lead generation approach.

引用

页码：63 / 78

页数：16

共 42 条

[21] Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings [J].

Lipinski, CA ;

Lombardo, F ;

Dominy, BW ;

Feeney, PJ .

ADVANCED DRUG DELIVERY REVIEWS, 1997, 23 (1-3) :3-25

[22] Muscarinic receptor 1 agonist activity of novel N-aryl carboxamide substituted 3-morpholino arecoline derivatives in Alzheimer's presenile dementia models [J].

Malviya, Manish ;

Kumar, Y. C. Sunil ;

Mythri, R. B. ;

Venkateshappa, C. ;

Subhash, M. N. ;

Rangappa, K. S. .

BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (15) :5526-5534

[23] Paw paw and cancer: Annonaceous acetogenins from discovery to commercial products [J].

McLaughlin, Jerry L. .

JOURNAL OF NATURAL PRODUCTS, 2008, 71 (07) :1311-1321

[24] CHOLINERGIC ACTIVITY OF ACETYLENIC IMIDAZOLES AND RELATED-COMPOUNDS [J].

MOON, MW ;

CHIDESTER, CG ;

HEIER, RF ;

MORRIS, JK ;

COLLINS, RJ ;

RUSSELL, RR ;

FRANCIS, JW ;

SAGE, GP ;

SETHY, VH .

JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (08) :2314-2327

[25] Can agricultural fungicides accelerate the discovery of human antifungal drugs? [J].

Myung, Kyung ;

Klittich, Carla J. R. .

DRUG DISCOVERY TODAY, 2015, 20 (01) :7-10

[26] Impacts of Bt Transgenic Cotton on Integrated Pest Management [J].

Naranjo, Steven E. .

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2011, 59 (11) :5842-5851

[27] TUMOR-CELL GROWTH-INHIBITION BY SEVERAL ANNONACEOUS ACETOGENINS IN AN IN-VITRO DISK DIFFUSION ASSAY [J].

OBERLIES, NH ;

JONES, JL ;

CORBETT, TH ;

FOTOPOULOS, SS ;

MCLAUGHLIN, JL .

CANCER LETTERS, 1995, 96 (01) :55-62

[28] Is there a difference between leads and drugs? A historical perspective [J].

Oprea, TI ;

Davis, AM ;

Teague, SJ ;

Leeson, PD .

JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2001, 41 (05) :1308-1315

[29]

Pharmaceutical Research and Manufacturers of America, 2013, BIOPH RES IND PROF

[30] NOVEL QUINUCLIDINE-BASED LIGANDS FOR THE MUSCARINIC CHOLINERGIC RECEPTOR [J].

SAUNDERS, J ;

CASSIDY, M ;

FREEDMAN, SB ;

HARLEY, EA ;

IVERSEN, LL ;

KNEEN, C ;

MACLEOD, AM ;

MERCHANT, KJ ;

SNOW, RJ ;

BAKER, R .

JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (04) :1128-1138

← 1 2 3 4 5 →